Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 24 Sep 21 424B3 Prospectus supplement
- 23 Sep 21 424B3 Prospectus supplement
- 23 Sep 21 EFFECT Notice of effectiveness
- 22 Sep 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Sep 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
17 Aug 21 S-4 Registration of securities issued in business combination transactions
SABS similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-4 and related joint proxy statement/prospectus of our reports dated June 17, 2021, with respect to the consolidated financial statements of SAB Biotherapeutics, Inc. as of December 31, 2020 and 2019 and for the years then ended, and to the reference to us under the heading “Experts” in the joint proxy statement/prospectus which is part of this Registration Statement.
/s/ Mayer Hoffman McCann P.C. | |
San Diego, California | |
August 16, 2021 |